Neuralert is developing a novel invention that addresses the problem of late or undetected stroke in hospitalized patients.
Verismo, a new cell therapy company pioneering multi-chain CAR-T technology, raised $16 million in equity financing.
The G2 Bio Companies, founded by James M. Wilson and the late Tachi Yamada, launched with a $200 million investment commitment from the global investment firm Temasek.
Iveric Bio entered into a sponsored research agreement with Drs. Karina Guziewicz and William Beltran both from the School of Veterinary Medicine.
Wharton Professor Susan Wachter is working with Freddie Mac to address the nation’s crisis of housing affordability which is worsening over time.
AbbVie has entered into two Sponsored Research Agreements with the lab of Gary Molander, PhD, Professor of Chemistry in the School of Arts & Sciences.
Awarded a patent that describes novel autophagy inhibitors potentially useful in cancer therapy.
Gene therapy pioneer invents new therapy to improve delivery of gene therapies to treat ocular diseases
Awarded a patent that describes mRNA trans-splicing as a gene therapy for treatment of ocular diseases caused by defects in large genes.
Arjun Raj, PhD, Assistant Professor in the School of Engineering, was awarded a patent for technology that captures an innovative method to detect Single Nucelotide Polymorphisms (SNPs).
A two-year-old Philadelphia gene therapy company spun out of the University of Pennsylvania has raised $76 million